{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:47:13Z","timestamp":1787237233820,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2005,2,18]],"date-time":"2005-02-18T00:00:00Z","timestamp":1108684800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1007\/s00467-004-1778-4","type":"journal-article","created":{"date-parts":[[2005,2,17]],"date-time":"2005-02-17T14:46:45Z","timestamp":1108651605000},"page":"482-485","source":"Crossref","is-referenced-by-count":45,"title":["Switch from cyclosporine A to mycophenolate mofetil in nephrotic children"],"prefix":"10.1007","volume":"20","author":[{"given":"Tim","family":"Ulinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Dubourg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie H\ufffdl\ufffdne","family":"Sa\ufffdd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Parchoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Ranchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Cochat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,2,18]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/ndt\/17.11.2011","volume":"17","author":"Day","year":"2002","unstructured":"Day CJ, Cockwell P, Lipkin GW, Savage CO, Howie AJ, Adu D (2002) Mycophenolate mofetil in the treatment of resistant idiopathic nephrotic syndrome. Nephrol Dial Transplant 17:2011?2013","journal-title":"Nephrol Dial Transplant"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s004670050044","volume":"14","author":"Seikaly","year":"2000","unstructured":"Seikaly MG, Prashner H, Nolde-Hurlbert B, Browne R (2000) Long-term clinical and pathological effects of cyclosporin in children with nephrosis. Pediatr Nephrol 14:214?217","journal-title":"Pediatr Nephrol"},{"key":"CR3","first-page":"165","volume":"44","author":"Allison","year":"1993","unstructured":"Allison AC, Eugui EM (1993) Immunosuppressive and other anti-rheumatic activities of mycophenolate mofetil. Agents Actions Suppl 44:165?188","journal-title":"Agents Actions Suppl"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00467-003-1175-4","volume":"18","author":"Barletta","year":"2003","unstructured":"Barletta GM, Smoyer WE, Bunchman TE, Flynn JT, Kershaw DB (2003) Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome. Pediatr Nephrol 18:833?837","journal-title":"Pediatr Nephrol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s00467-003-1174-5","volume":"18","author":"Montane","year":"2003","unstructured":"Montane B, Abitbol C, Chandar J, Strauss J, Zilleruelo G (2003) Novel therapy of focal glomerulosclerosis with mycophenolate and angiotensin blockade. Pediatr Nephrol 18:772?777","journal-title":"Pediatr Nephrol"},{"key":"CR6","first-page":"15","volume":"23","author":"Eugui","year":"1991","unstructured":"Eugui EM, Mirkovich A, Allison AC (1991) Lymphocyte-selective antiproliferative and immunosuppressive activity of mycophenolic acid and its morpholinoethyl ester (RS-61443) in rodents. Transplant Proc 23:15?18","journal-title":"Transplant Proc"},{"key":"CR7","first-page":"67","volume":"25","author":"Allison","year":"1993","unstructured":"Allison AC, Kowalski WJ, Muller CJ, Waters RV, Eugui EM (1993) Mycophenolic acid and brequinar, inhibitors of purine and pyrimidine synthesis, block the glycosylation of adhesion molecules. Transplant Proc 25:67?70","journal-title":"Transplant Proc"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF00192309","volume":"14","author":"Allison","year":"1993","unstructured":"Allison AC, Eugui EM (1993) The design and development of an immunosuppressive drug, mycophenolate mofetil. Springer Semin Immunopathol 14:353?380","journal-title":"Springer Semin Immunopathol"},{"key":"CR9","first-page":"8","volume":"3","author":"Chang","year":"1993","unstructured":"Chang CC, Naiki M, Halpern GM, Gershwin ME (1993) Pharmacological regulation of the immune system. J Investig Allergol Clin Immunol 3:8?18","journal-title":"J Investig Allergol Clin Immunol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1749-6632.1993.tb17146.x","volume":"696","author":"Chang","year":"1993","unstructured":"Chang CC, Aversa G, Punnonen J, Yssel H, de Vries JE (1993) Brequinar sodium, mycophenolic acid, and cyclosporin A inhibit different stages of IL-4- or IL-13-induced human IgG4 and IgE production in vitro. Ann NY Acad Sci 696:108?122","journal-title":"Ann NY Acad Sci"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/ndt\/14.1.58","volume":"14","author":"Hauser","year":"1999","unstructured":"Hauser IA, Renders L, Radeke HH, Sterzel RB, Goppelt-Struebe M (1999) Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion. Nephrol Dial Transplant 14:58?63","journal-title":"Nephrol Dial Transplant"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/00007890-199511270-00015","volume":"60","author":"Senda","year":"1995","unstructured":"Senda M, DeLustro B, Eugui E, Natsumeda Y (1995) Mycophenolic acid, an inhibitor of IMP dehydrogenase that is also an immunosuppressive agent, suppresses the cytokine-induced nitric oxide production in mouse and rat vascular endothelial cells. Transplantation 60:1143?1148","journal-title":"Transplantation"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00007890-199908150-00014","volume":"68","author":"Cohn","year":"1999","unstructured":"Cohn RG, Mirkovich A, Dunlap B, Burton P, Chiu SH, Eugui E, Caulfield JP (1999) Mycophenolic acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell lines. Transplantation 68:411?418","journal-title":"Transplantation"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1681\/ASN.V9122272","volume":"9","author":"Penny","year":"1998","unstructured":"Penny MJ, Boyd RA, Hall BM (1998) Mycophenolate mofetil prevents the induction of active Heymann nephritis: association with Th2 cytokine inhibition. J Am Soc Nephrol 9:2272?2282","journal-title":"J Am Soc Nephrol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1681\/ASN.V112283","volume":"11","author":"Fujihara","year":"2000","unstructured":"Fujihara CK, De Lourdes Noronha I, Malheiros, Antunes GR, de Oliveira IB, Zatz R (2000) Combined mycophenolate mofetil and losartan therapy arrests established injury in the remnant kidney. J Am Soc Nephrol 11:283?290","journal-title":"J Am Soc Nephrol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/ki.1997.217","volume":"51","author":"Corna","year":"1997","unstructured":"Corna D, Morigi M, Facchinetti D, Bertani T, Zoja C, Remuzzi G (1997) Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease. Kidney Int 51:1583?1589","journal-title":"Kidney Int"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00467-003-1300-4","volume":"19","author":"Gellermann","year":"2004","unstructured":"Gellermann J, Querfeld U (2004) Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil. Pediatr Nephrol 19:101?104","journal-title":"Pediatr Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-004-1778-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-004-1778-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-004-1778-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T01:05:19Z","timestamp":1625447119000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-004-1778-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,18]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["1778"],"URL":"https:\/\/doi.org\/10.1007\/s00467-004-1778-4","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,18]]}}}